The Side Effects of Imatinib

The Side Effects of Imatinib

Show other versions (1)

-

Bibliographic Details
Main Authors:	Elmas Uzer, Ali Ünal, M. Yavuz Köker, Suat Ali Doğan
Format:	Article
Language:	English
Published:	Galenos Publishing House 2013-09-01
Series:	Turkish Journal of Hematology
Subjects:	-
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-13334

Similar Items

The Side Effects of Imatinib
by: Elmas Uzer, et al.
Published: (2013-09-01)

Sigmoid Sinus Thrombosis Followed by Splenic Infarction Due to Imatinib Therapy in a Patient with Gastrointestinal Stromal Tumor; Hematological Side Effects of Imatinib
by: Hatice YILMAZ, et al.
Published: (2021-03-01)

IMATINIB IN CHRONIC MYELOID LEUKEMIA: PATIENT-REPORTED SIDE EFFECTS AND THEIR INFLUENCE ON QUALITY OF LIFE
by: Faisal Mehmood, et al.
Published: (2018-06-01)

Effect of astaxanthin in imatinib mesylate-induced cardiotoxicity
by: İshak Suat Övey, et al.
Published: (2020-03-01)

Imatinib-associated hyperpigmentation, a side effect that should be recognized.
by: Mcpherson, T, et al.
Published: (2009)

Melasma-like hyperpigmentation: A rare side effect of imatinib mesylate
by: Shreya Agrawal, et al.
Published: (2023-01-01)

Determination of drug sensitivity subgroups in acute myeloid leukemia to increase treatment efficacy by imatinib and its analog imatinib B
by: Can Turk, et al.
Published: (2021-09-01)

Imatinibe mesilato no Brasil Imatinibe mesylate in Brazil
by: Marcos Lima
Published: (2005-09-01)

Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a german multicenter trial
by: Schlemmer M, et al.
Published: (2011-05-01)

Effects of Imatinib on Rat Liver
by: Yurdun Kuyucu, et al.
Published: (2021-01-01)

Primary imatinib failure rescued by dasatinib and maintained by reintroduction of imatinib
by: Rajiv Kumar, et al.

Imatinib en leucemia mieloide crónica Imatinib in chronic myeloid leukemia
by: Valia Pavón Morán, et al.
Published: (2005-12-01)

HEPATOTOXICIDADE PELO IMATINIB
by: VALC Filho, et al.
Published: (2023-10-01)

The teratogenic effects of imatinib mesylate on rat fetuses
by: M.M. El Gendy, et al.
Published: (2015-01-01)

Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine
by: Aktas Esin, et al.
Published: (2011-06-01)

Imatinib Use in Pregnancy
by: Michael J Webb, et al.
Published: (2012-12-01)

Imatinib-Induced Psoriasis
by: Figen Atalay, et al.
Published: (2013-06-01)

Survival of Patients with CML on Imatinib Experience with 44 Iraqi Patients
by: Ali M. Jawad, et al.
Published: (2008-10-01)

The effect of grape seed and green tea extracts on the pharmacokinetics of imatinib and its main metabolite, N-desmethyl imatinib, in rats
by: Ruba S. Darweesh, et al.
Published: (2020-11-01)

Imatinib Therapy in Chronic Myelogenous Leukemia and Thyroid Function Tests
by: Mohammad Ali Mashhadi, et al.
Published: (2014-09-01)

Imatinib activity on Schistosoma mansoni
by: Naftale Katz, et al.
Published: (2013-11-01)

Imatinib induced lichen planus
by: R Sudha, et al.
Published: (2011-01-01)

Correction: Exploiting the promiscuity of imatinib
by: Lee Shun J, et al.
Published: (2010-06-01)

Therapeutic drug monitoring of imatinib
by: Pierre Wallemacq
Published: (2011-01-01)

Nilotinib after imatinib failure
by: Luca Pezzullo
Published: (2015-10-01)

GENERIC IMATINIB VS GLEEVEC
by: Katia Borgia Barbosa Pagnano
Published: (2021-11-01)

Protective Effects of Imatinib and Ginkgo Biloba on Cisplatin-induced Ovarian Damage in Rats
by: Önder Sakin, et al.
Published: (2020-07-01)

Dasatinib treatment of imatinib-resistant and imatinib-intolerant patients with chronic myeloid leukemia in a chronic phase
by: Ol'ga Yur'evna Vinogradova, et al.
Published: (2009-07-01)

Adverse effects of Imatinib in patients with chronic myeloid leukemia
by: Hajar Masrour, et al.
Published: (2023-01-01)

Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines
by: Esma Bilajac, et al.
Published: (2022-12-01)

Defining the target and the effect of imatinib on the filarial c-Abl homologue.
by: Elise M O'Connell, et al.
Published: (2017-07-01)

Caffeic Acid Enhances the Anti-Leukemic Effect of Imatinib on Chronic Myeloid Leukemia Cells and Triggers Apoptosis in Cells Sensitive and Resistant to Imatinib
by: Giordana Feriotto, et al.
Published: (2021-02-01)

Quantitative determination of imatinib stability under various stress conditions
by: Khalid Mohammed Alkharfy, et al.
Published: (2013-01-01)

An Atypical Case with Chronic Granulomatous Disease and Kabuki Syndrome
by: Mustafa Yavuz Köker, et al.
Published: (2020-04-01)

Drug-induced hyperpigmentation due to imatinib
by: Savitha Murali, et al.
Published: (2023-01-01)

Imatinib Sets Pericyte Mosaic in the Retina
by: Tamás Kovács-Öller, et al.
Published: (2020-04-01)

Imatinib associated temporal bone osteonecrosis
by: Dominic McKenna, et al.
Published: (2023-07-01)

Imatinib-induced melasma-like pigmentation
by: Sweta Subhadarshani, et al.
Published: (2019-01-01)

Imatinib resistance: diagnostic and therapeutic choices
by: Marianna De Muro, et al.
Published: (2015-10-01)

CostPlus and implications for generic imatinib
by: Kristina Jenei, et al.
Published: (2022-09-01)